Comment from National Center for Health Research

Summary: The National Center for Health Research (NCHR), a nonprofit organization, opposes the proposed Expedited Investigational New Drug (IND) Pilot Program as currently structured. They argue that the sponsor-funded model creates significant conflicts of interest and potential biases that could compromise participant safety and independent scientific oversight.